VM 536 Day 8 Small Airway Small Animal post class 2021
Patient: Gandalf, 8-year-old Neutered Domestic Longhair (DLH)
Chief Complaint: Persistent cough for 6 months; miscommunication regarding the purpose of the appointment.
Source: Rescued from a Humane Society
Household: Lives with one dog; single cat household
Lifestyle: Indoor/outdoor access
Symptoms:
"Always coughs a bit"
Episodes of orthopnea and open-mouth breathing after play or outdoor activity
Otherwise appears healthy
Vaccination Status: Up to date with FVRCP, FeLV, Rabies, flea, and tick preventive.
Vital Signs:
Temperature: 99.5°F (normal range 100.5 - 103°F)
Pulse: 180 bpm (normal range 120 - 220 bpm)
Respiratory Rate: 40 bpm (normal range 16 - 32 bpm)
CRT: <2s, mucous membranes pink.
Auscultation Findings:
Notable expiratory effort
Bronchovesicular sounds and occasional expiratory wheezes
Body Condition Score: 6/9, weight at 12 lbs.
Results:
CBC: Normal
Chemistry: Normal
Urinalysis: Normal
History:
Cough
Episodic orthopnea
Physical Exam Findings:
Expiratory effort
Loud bronchovesicular sounds
Expiratory wheezes
Overweight status (BCS 6/9)
Differential Diagnoses: Investigation ongoing.
Planned Diagnostics:
Thoracic radiographs
Fecal flotation
Heartworm test
Thoracic Radiographs:
Mild, diffuse bronchial/bronchiolar pattern observed
Mild aerophagia noted
Fecal Examinations:
Flotation: Negative
Sedimentation: Negative
Baermann: Negative
Heartworm Antibody Test: Negative
Other Tests: Aelurostrongylus abstrusus larvae and Snap Feline Triple test performed.
Chronic Cough Causes:
Heartworm disease
Chronic bronchitis
Asthma
Bronchopneumonia
Pulmonary parasites
Foreign bodies
Neoplasia
Dynamic Lower Airway Disease Indicators:
Asthma
Chronic bronchitis
Heart disease
Neoplasia
Radiographic Patterns:
Indicative of asthma or bronchitis (chronic, viral, etc) or neoplasia.
Preparation: Fasted overnight
Medications:
Terbutaline (0.6 mg SQ) - beta-adrenergic agonist
Propofol - Short-acting injectable anesthetic
Pre-oxygenation prior to procedure.
Cell Type Distribution:
Eosinophils: 75%
Macrophages: 15%
Neutrophils: 10%
Squamous epithelial cells present
Ciliated columnar epithelial cells present.
Clinical Signs Associated with Persistent Inflammation:
Chronic cough
Bronchoconstriction
Mucus hypersecretion
Airway obstruction
Morphological Changes:
Mucous cell metaplasia
Smooth muscle hypertrophy
Change from reversible to irreversible obstruction.
Medications:
Short-acting corticosteroids (Dexamethasone) for emergency therapy, advantages include bioavailability, cost, and speed of action.
Consideration for additional respiratory support: oxygen therapy and bronchodilators (Terbutaline 0.01 mg/kg IV, SQ).
Medications:
Oral prednisolone (2 mg/kg/day divided BID), tapering to lowest effective dose.
Inhaled glucocorticoids (Fluticasone propionate) for less systemic effects but may be expensive and have a learning curve.
Purpose: Deliver glucocorticoids and bronchodilators for chronic airway disease.
Features:
Designed to aerosolize medications for optimum deposition in airways.
Spacer device enhances efficacy of drug delivery.
Initial Evaluation:
Monitoring cough counts, resting respiratory rate, and general activity.
If Ineffective:
Screen for complications and other co-morbidities.
Adjust anti-inflammatory therapy or consider bronchodilators.
Characteristics:
Recurrent collapse of right middle lung; common in asthma and chronic bronchitis.
Factors Influencing Syndrome:
Anatomical (narrow lobar bronchus, gravity effects)
Pathological (mucus hypersecretion, bronchospasm).
Clinical Signs: Persistent cough and bronchial inflammation even with treatment.
Patient: Gandalf, 8-year-old Neutered Domestic Longhair (DLH)
Chief Complaint: Persistent cough for 6 months; miscommunication regarding the purpose of the appointment.
Source: Rescued from a Humane Society
Household: Lives with one dog; single cat household
Lifestyle: Indoor/outdoor access
Symptoms:
"Always coughs a bit"
Episodes of orthopnea and open-mouth breathing after play or outdoor activity
Otherwise appears healthy
Vaccination Status: Up to date with FVRCP, FeLV, Rabies, flea, and tick preventive.
Vital Signs:
Temperature: 99.5°F (normal range 100.5 - 103°F)
Pulse: 180 bpm (normal range 120 - 220 bpm)
Respiratory Rate: 40 bpm (normal range 16 - 32 bpm)
CRT: <2s, mucous membranes pink.
Auscultation Findings:
Notable expiratory effort
Bronchovesicular sounds and occasional expiratory wheezes
Body Condition Score: 6/9, weight at 12 lbs.
Results:
CBC: Normal
Chemistry: Normal
Urinalysis: Normal
History:
Cough
Episodic orthopnea
Physical Exam Findings:
Expiratory effort
Loud bronchovesicular sounds
Expiratory wheezes
Overweight status (BCS 6/9)
Differential Diagnoses: Investigation ongoing.
Planned Diagnostics:
Thoracic radiographs
Fecal flotation
Heartworm test
Thoracic Radiographs:
Mild, diffuse bronchial/bronchiolar pattern observed
Mild aerophagia noted
Fecal Examinations:
Flotation: Negative
Sedimentation: Negative
Baermann: Negative
Heartworm Antibody Test: Negative
Other Tests: Aelurostrongylus abstrusus larvae and Snap Feline Triple test performed.
Chronic Cough Causes:
Heartworm disease
Chronic bronchitis
Asthma
Bronchopneumonia
Pulmonary parasites
Foreign bodies
Neoplasia
Dynamic Lower Airway Disease Indicators:
Asthma
Chronic bronchitis
Heart disease
Neoplasia
Radiographic Patterns:
Indicative of asthma or bronchitis (chronic, viral, etc) or neoplasia.
Preparation: Fasted overnight
Medications:
Terbutaline (0.6 mg SQ) - beta-adrenergic agonist
Propofol - Short-acting injectable anesthetic
Pre-oxygenation prior to procedure.
Cell Type Distribution:
Eosinophils: 75%
Macrophages: 15%
Neutrophils: 10%
Squamous epithelial cells present
Ciliated columnar epithelial cells present.
Clinical Signs Associated with Persistent Inflammation:
Chronic cough
Bronchoconstriction
Mucus hypersecretion
Airway obstruction
Morphological Changes:
Mucous cell metaplasia
Smooth muscle hypertrophy
Change from reversible to irreversible obstruction.
Medications:
Short-acting corticosteroids (Dexamethasone) for emergency therapy, advantages include bioavailability, cost, and speed of action.
Consideration for additional respiratory support: oxygen therapy and bronchodilators (Terbutaline 0.01 mg/kg IV, SQ).
Medications:
Oral prednisolone (2 mg/kg/day divided BID), tapering to lowest effective dose.
Inhaled glucocorticoids (Fluticasone propionate) for less systemic effects but may be expensive and have a learning curve.
Purpose: Deliver glucocorticoids and bronchodilators for chronic airway disease.
Features:
Designed to aerosolize medications for optimum deposition in airways.
Spacer device enhances efficacy of drug delivery.
Initial Evaluation:
Monitoring cough counts, resting respiratory rate, and general activity.
If Ineffective:
Screen for complications and other co-morbidities.
Adjust anti-inflammatory therapy or consider bronchodilators.
Characteristics:
Recurrent collapse of right middle lung; common in asthma and chronic bronchitis.
Factors Influencing Syndrome:
Anatomical (narrow lobar bronchus, gravity effects)
Pathological (mucus hypersecretion, bronchospasm).
Clinical Signs: Persistent cough and bronchial inflammation even with treatment.